Prevalence, distribution and functional significance of the -237C to T polymorphism in the IL-12Rβ2 promoter in Indian tuberculosis patients

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Verma, Vikas Kumar ^a   Taneja, Vibha ^a   Jaiswal, Anand ^b   Sharma, Sangeeta ^b   Behera, Digamber ^b   Sreenivas, Vishnubhatla ^a   Chauhan, Shyam Singh ^a   Prasad, Hanumanthappa Krishna ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b LRS Institute of Tuberculosis and Respiratory Diseases   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 12 RECEPTOR BETA2; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 4; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG; IL12RB2 PROTEIN, HUMAN; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 4;

ADULT; ALLELE; AMPLICON; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE ACTIVITY; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; IL12R BETA2 GENE; IMMUNOMODULATION; IN VITRO STUDY; INDIAN; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN; GENE EXPRESSION REGULATION; GENETICS; INDIA; METABOLISM; NUCLEOTIDE SEQUENCE;

MYCOBACTERIUM TUBERCULOSIS;

ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; INDIA; INTERFERON-ALPHA; INTERLEUKIN-4; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, INTERLEUKIN-12; RNA, MESSENGER; TUBERCULOSIS, PULMONARY;

EID: 84859257147     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034355     Document Type: Article

References (51)

1. World Health Organization website. Available: http://www.who.int/tb/publications/2009/tbfactsheet_2009update_one_page.pdf. Accessed 2011 Aug 8.
2. van Deventer SJ, (2000) Cytokine and cytokine receptor polymorphisms in infectious disease. Intensive Care Med 26 (Suppl 1): S98-102.
3. Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, et al. (1999) Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1: 3-19.
4. Yim JJ, Selvaraj P, (2010) Genetic susceptibility in tuberculosis. Respirology 15: 241-256.
5. Knight JC, (2004) Allele-specific gene expression uncovered. Trends Genet 20: 113-116.
6. Chua AO, Wilkinson VL, Presky DH, Gubler U, (1995) Cloning and characterization of a mouse IL-12 receptor-beta component. J Immunol 155: 4286-4294.
7. Rogge L, Barberis-Maino L, Biffi M, Passini N, Presky DH, et al. (1997) Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 185: 825-831.
8. Szabo SJ, Dighe AS, Gubler U, Murphy KM, (1997) Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med 185: 817-824.
9. van Rietschoten JG, Smits HH, van de Wetering D, Westland R, Verweij CL, et al. (2001) Silencer activity of NFATc2 in the interleukin-12 receptor beta 2 proximal promoter in human T helper cells. J Biol Chem 276: 34509-34516.
10. van Rietschoten JG, Westland R, van den Bogaard R, Nieste-Otter MA, van Veen A, et al. (2004) A novel polymorphic GATA site in the human IL-12Rbeta2 promoter region affects transcriptional activity. Tissue Antigens 63: 538-546.
11. Hu YF, Luscher B, Admon A, Mermod N, Tjian R, (1990) Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity. Genes Dev 4: 1741-1752.
12. Yagi R, Zhu J, Paul WE, (2011) An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation. Int Immunol 23: 415-420.
13. Letimier FA, Passini N, Gasparian S, Bianchi E, Rogge L, (2007) Chromatin remodeling by the SWI/SNF-like BAF complex and STAT4 activation synergistically induce IL-12Rbeta2 expression during human Th1 cell differentiation. Embo J 26: 1292-1302.
14. Mermod N, Williams TJ, Tjian R, (1988) Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro. Nature 332: 557-561.
15. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
16. Ohyama H, Ogata K, Takeuchi K, Namisato M, Fukutomi Y, et al. (2005) Polymorphism of the 5′ flanking region of the IL-12 receptor beta2 gene partially determines the clinical types of leprosy through impaired transcriptional activity. J Clin Pathol 58: 740-743.
17. Liang L, Zhao YL, Yue J, Liu JF, Han M, et al. (2011) Interleukin-10 gene promoter polymorphisms and their protein production in pleural fluid in patients with tuberculosis. FEMS Immunol Med Microbiol 62: 84-90.
18. Rosenzweig SD, Schaffer AA, Ding L, Sullivan R, Enyedi B, et al. (2004) Interferon-gamma receptor 1 promoter polymorphisms: population distribution and functional implications. Clin Immunol 112: 113-119.
19. Keen LJ, (2002) The extent and analysis of cytokine and cytokine receptor gene polymorphism. Transpl Immunol 10: 143-146.
20. Smith AJ, Humphries SE, (2009) Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 20: 43-59.
21. Matsui E, Kaneko H, Fukao T, Teramoto T, Inoue R, et al. (1999) Mutations of the IL-12 receptor beta2 chain gene in atopic subjects. Biochem Biophys Res Commun 266: 551-555.
22. Watford WT, Moriguchi M, Morinobu A, O'Shea JJ, (2003) The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine & Growth Factor Reviews 14: 361-368.
23. Imai K, Okamoto T, (2006) Transcriptional repression of human immunodeficiency virus type 1 by AP-4. J Biol Chem 281: 12495-12505.
24. Kim JW, Monila H, Pandey A, Lane MD, (2007) Upstream stimulatory factors regulate the C/EBP alpha gene during differentiation of 3T3-L1 preadipocytes. Biochem Biophys Res Commun 354: 517-521.
25. Ma SL, Tang NL, Tam CW, Cheong Lui VW, Lam LC, et al. (2010) A PIN1 polymorphism that prevents its suppression by AP4 associates with delayed onset of Alzheimer's disease. Neurobiol Aging.
26. Huber JP, Ramos HJ, Gill MA, Farrar JD, Cutting edge: Type I IFN reverses human Th2 commitment and stability by suppressing GATA3. J Immunol 185: 813-817.
27. Zaki MH, Shane RB, Geng Y, Showe LC, Everetts SE, et al. (2001) Dysregulation of lymphocyte interleukin-12 receptor expression in Sezary syndrome. J Invest Dermatol 117: 119-127.
28. Zhang M, Gong J, Presky DH, Xue W, Barnes PF, (1999) Expression of the IL-12 receptor beta 1 and beta 2 subunits in human tuberculosis. J Immunol 162: 2441-2447.
29. Toh ML, Kawashima M, Zrioual S, Hot A, Miossec P, et al. (2009) IL-17 inhibits human Th1 differentiation through IL-12R beta 2 downregulation. Cytokine 48: 226-230.
30. Wu CY, Wang K, McDyer JF, Seder RA, (1998) Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J Immunol 161: 2723-2730.
31. Seah GT, Scott GM, Rook GA, (2000) Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis 181: 385-389.
32. Sarma GR, Immanuel C, Ramachandran G, Krishnamurthy PV, Kumaraswami V, et al. (1990) Adrenocortical function in patients with pulmonary tuberculosis. Tubercle 71: 277-282.
33. Bhattacharyya S, Singla R, Dey AB, Prasad HK, (1999) Dichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosis. Infect Immun 67: 5597-5603.
34. Gupta V, Jaiswal A, Behera D, Prasad HK, (2010) Disparity in circulating peripheral blood dendritic cell subsets and cytokine profile of pulmonary tuberculosis patients compared with healthy family contacts. Hum Immunol.
35. Rayamajhi M, Humann J, Penheiter K, Andreasen K, Lenz LL, (2010) Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma. J Exp Med 207: 327-337.
36. Liu BS, Janssen HL, Boonstra A, (2011) IL-29 and IFNalpha differ in their ability to modulate IL-12 production by TLR-activated human macrophages and exhibit differential regulation of the IFNgamma receptor expression. Blood 117: 2385-2395.
37. Singhal A, Jaiswal A, Arora VK, Prasad HK, (2007) Modulation of gamma interferon receptor 1 by Mycobacterium tuberculosis: a potential immune response evasive mechanism. Infect Immun 75: 2500-2510.
38. Taha RA, Kotsimbos TC, Song YL, Menzies D, Hamid Q, (1997) IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis. Am J Respir Crit Care Med 155: 1135-1139.
39. Zhao Z, Yu S, Fitzgerald DC, Elbehi M, Ciric B, et al. (2008) IL-12R beta 2 promotes the development of CD4+CD25+ regulatory T cells. J Immunol 181: 3870-3876.
40. Burl S, Hill PC, Jeffries DJ, Holland MJ, Fox A, et al. (2007) FOXP3 gene expression in a tuberculosis case contact study. Clin Exp Immunol 149: 117-122.
41. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A, (2006) Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 173: 803-810.
42. Hori S, Nomura T, Sakaguchi S, (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
43. Taha RA, Minshall EM, Olivenstein R, Ihaku D, Wallaert B, et al. (1999) Increased expression of IL-12 receptor mRNA in active pulmonary tuberculosis and sarcoidosis. Am J Respir Crit Care Med 160: 1119-1123.
44. Keerthivasan S, Keerthivasan G, Mittal S, Chauhan SS, (2007) Transcriptional upregulation of human cathepsin L by VEGF in glioblastoma cells. Gene 399: 129-136.
45. Schreiber E, Matthias P, Muller MM, Schaffner W, (1989) Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 17: 6419.
46. Cheng CK, Hoo RL, Chow BK, Leung PC, (2003) Functional cooperation between multiple regulatory elements in the untranslated exon 1 stimulates the basal transcription of the human GnRH-II gene. Mol Endocrinol 17: 1175-1191.
47. Rodriguez-Antona C, Bort R, Jover R, Tindberg N, Ingelman-Sundberg M, et al. (2003) Transcriptional regulation of human CYP3A4 basal expression by CCAAT enhancer-binding protein alpha and hepatocyte nuclear factor-3 gamma. Mol Pharmacol 63: 1180-1189.
48. Boeuf P, Vigan-Womas I, Jublot D, Loizon S, Barale JC, et al. (2005) CyProQuant-PCR: a real time RT-PCR technique for profiling human cytokines, based on external RNA standards, readily automatable for clinical use. BMC Immunol 6: 5.
49. Mantel PY, Kuipers H, Boyman O, Rhyner C, Ouaked N, et al. (2007) GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol 5: e329.
50. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
51. Jaberipour M, Baharlou R, Hosseini A, Talei A, Razmkhah M, et al. (2011) Increased IL-17 and IL-6 Transcripts in Peripheral Blood Mononuclear Cells: Implication for a Robust Proinflammatory Response in Early Stages of Breast Cancer. Middle East Journal of Cancer 2: 19-26.